Curative Biotechnology

Curative Biotechnology P/B

The P/B (Price-to-Book Ratio) of Curative Biotechnology (CUBT) as of Oct 15, 2026 is -1.20. In the previous year, P/B (Price-to-Book Ratio) was -1.49 — a change of -19.29% (higher).

P/B

-1.20

YoY

-19.29%

Last updated:

P/B (Price-to-Book Ratio) of Curative Biotechnology is 2025 -1.20 . P/B (Price-to-Book Ratio) of Curative Biotechnology was 2024 -1.49 . It decreases by -19.29% higher compared to the previous year.

The Curative Biotechnology P/B history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/B
Date
P/B
Jan 1, 2018
-10.61 USD
Jan 1, 2019
-20.46 USD
Jan 1, 2020
-1.62 USD
Jan 1, 2021
4.35 USD
Jan 1, 2022
-2.88 USD
Jan 1, 2023
-2.33 USD
Jan 1, 2024
-1.49 USD
Jan 1, 2025
-1.20 USD
The Curative Biotechnology P/B history
YEARP/BYoY
-1.20-19.29%
-1.49-36.03%
-2.33-19.23%
-2.88-166.26%
4.35-368.85%
-1.62-92.10%
-20.46+92.90%
-10.61-4.34%
-11.09-3.49%
-11.49-2.73%
-11.81+25.01%
-9.45—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Curative Biotechnology Stock analysis

What does Curative Biotechnology do? Curative Biotechnology is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Curative Biotechnology stock

P/B (Price-to-Book Ratio) of Curative Biotechnology is -1.20 in 2025.

P/B (Price-to-Book Ratio) of Curative Biotechnology changed from -1.49 to -1.20, representing a -19.29% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of P/B (Price-to-Book Ratio) Curative Biotechnology since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Book ratio compares a company's market price to its book value. A low P/B may indicate an undervalued stock, while a high P/B could suggest overvaluation or strong growth expectations.

P/B = Stock Price / Book Value per Share

To evaluate P/B (Price-to-Book Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/B (Price-to-Book Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/B (Price-to-Book Ratio)'s Curative Biotechnology with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Curative Biotechnology

All Key Metrics — Curative Biotechnology